Auctus Biologics is a biotechnology company that develops antibody mimetics for therapeutic and diagnostic applications.
Auctus Biologics has raised $229K in total funding. The most recent round was Grant. The last funding was announced in February 2022.
Auctus Biologics's investors include National Science Foundation, Grapeseed.Bio, Dennis Sanche.
Auctus Biologics is headquartered in Lafayette, United States.
Auctus Biologics is a biotechnology company that develops antibody mimetics for therapeutic and diagnostic applications.
Auctus Biologics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Auctus Biologics — Funding & Investors." VCBacked, February 9, 2022, https://www.vcbacked.co/company/auctus-biologics. Accessed November 13, 2026.
VCBacked. (2022). Auctus Biologics — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/auctus-biologics
{{cite web |title=Auctus Biologics — Funding & Investors |url=https://www.vcbacked.co/company/auctus-biologics |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Auctus Biologics? Request a listing update